antifungal therapy – Page 12

Folliculocentric tinea versicolor: a case report

mycolabadmin

A 46-year-old woman was diagnosed with an unusual presentation of tinea versicolor, a common fungal skin infection, where the fungus centered around hair follicles rather than appearing as typical patches. The condition was successfully treated with antifungal medications, though some changes persisted. The doctors noted that the patient’s history of keratosis pilaris (a common bumpy skin condition on the arms and thighs) may have contributed to this unusual follicle-focused presentation.

Photo Quiz: A cutaneous fungal infection with discordant biomarker results—a diagnostic challenge

mycolabadmin

A woman with advanced HIV infection presented with skin sores and respiratory symptoms that were initially suspected to be a viral infection. Testing revealed she had histoplasmosis, a serious fungal infection caused by Histoplasma capsulatum that had spread throughout her body affecting her skin, lungs, and lymph nodes. While standard tests for this fungus were negative, other fungal markers and cultures eventually confirmed the diagnosis, and she was treated with antifungal medications.

Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient

mycolabadmin

A 5-year-old girl with systemic juvenile arthritis being treated with immunosuppressive medications developed a rare and serious fungal infection in her nose and sinuses caused by a mold called Lichtheimia. The infection caused tissue death and spread toward her brain, but was successfully treated with combination antifungal drugs and surgery. This case highlights how powerful immunosuppressive treatments for severe arthritis can increase the risk of life-threatening fungal infections.

The Antimicrobial Extract Derived from Pseudomonas sp. HP-1 for Inhibition of Aspergillus flavus Growth and Prolongation of Maize Seed Storage

mycolabadmin

Researchers discovered that a beneficial bacterium called Pseudomonas sp. HP-1 can produce a natural compound that effectively prevents mold contamination in stored maize seeds. The extract from this bacterium showed strong antifungal activity against Aspergillus flavus, a major cause of aflatoxin contamination in grain storage. The main protective compound was identified as phenazinecarboxylic acid, which works by damaging the cell membranes of fungal cells. This finding offers a promising eco-friendly alternative to synthetic chemical fungicides for protecting stored crops.

Histoplasma capsulatum prosthetic valve endocarditis treated with oral isavuconazole

mycolabadmin

A 76-year-old man developed a rare fungal infection on his artificial heart valve caused by Histoplasma capsulatum, a fungus found in soil and bird droppings. After surgery to replace the infected valve, he was treated with isavuconazole, an antifungal medication that proved highly effective and better tolerated than traditional treatments. After nine months of therapy, all signs of infection had resolved and his new valve was working properly.

Successful management of Lomentospora prolificans septic arthritis and osteomyelitis in an immunocompetent child: A case report

mycolabadmin

A 3-year-old boy developed a serious fungal bone and joint infection caused by Lomentospora prolificans after surgery to fix a broken elbow. This fungus is extremely resistant to most antifungal medications. The infection was successfully treated using multiple approaches: aggressive surgical cleaning, several different antifungal drugs used together, special antibiotic-loaded bone cement, and antiseptic rinses. After two months of intensive treatment, the infection cleared and the child’s arm was saved from amputation.

Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model

mycolabadmin

Researchers developed special nanoparticles that can cross the protective barrier surrounding the brain by using a protein from a fungal infection. These nanoparticles are loaded with an antifungal drug and can effectively treat cryptococcal brain infections in laboratory tests. This approach offers a new way to deliver medicines to the brain without invasive procedures, potentially helping patients with serious brain infections that are currently difficult to treat.

Comparative Study and Transcriptomic Analysis on the Antifungal Mechanism of Ag Nanoparticles and Nanowires Against Trichosporon asahii

mycolabadmin

Researchers compared two types of tiny silver particles (nanoparticles and nanowires) as potential treatments for a dangerous fungal infection caused by Trichosporon asahii. Silver nanowires were found to be more effective than nanoparticles at killing the fungus by damaging its cell membranes and disrupting its energy production. The study identified 15 key genes involved in how silver nanowires attack the fungus, suggesting these nanomaterials could become useful alternatives to traditional antifungal drugs.

Invasive nasal and paranasal mucormycosis in a patient with severe dengue fever and multiple risk factors: A case report and literature review

mycolabadmin

A 50-year-old woman in Vietnam developed a rare and deadly fungal infection called mucormycosis while recovering from dengue fever. She had weakened immunity from taking steroids for other conditions and from the dengue virus itself. The infection caused black, dead tissue to rapidly spread in her nose and around her eye. Despite treatment with antifungal medications, the infection progressed, and she died within days. The case shows how important it is to watch for dangerous opportunistic infections in dengue patients, especially those already dealing with weakened immune systems.

Staurosporine as an Antifungal Agent

mycolabadmin

Staurosporine is a natural compound from soil bacteria that can kill fungal infections. While originally known for its anti-cancer properties, scientists have recently rediscovered its strong antifungal activity, especially against dangerous drug-resistant fungi. The challenge is that it also damages human cells, but researchers are developing improved versions and combination treatments to make it safer and more effective.

Research Keyword: antifungal therapy